Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-26T07:33:48.076Z Has data issue: false hasContentIssue false

Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers

Published online by Cambridge University Press:  02 January 2015

Amy L. Pakyz
Affiliation:
School of Pharmacy, Department of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond
Holly E. Gurgle
Affiliation:
School of Pharmacy, Department of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond
Omar M. Ibrahim
Affiliation:
School of Pharmacy, Department of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond
Michael J. Oinonen
Affiliation:
University HealthSystem Consortium, Oak Brook, Illinois
Ronald E. Polk
Affiliation:
School of Pharmacy, Department of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond

Abstract

Trends in pediatric antibacterial use were examined in 20 academic health centers during the period 2002-2007. There was a significant increase in the use of linezolid (P < .001) and of macrolides (P = .001) and a significant decrease in the use of aminoglycosides (P < .001) and of first-generation cephalosporins (P < .001).

Type
Concise Communications
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.McCaig, LF, Besser, RE, Hughes, JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002;287:30963102.CrossRefGoogle ScholarPubMed
2.Linder, JA, Bates, DW, Lee, GM, Finkelstein, JA. Antibiotic treatment of children with sore throat. JAMA 2005;294:23152322.Google Scholar
3.Stille, CI, Andrade, SE, Huang, SS, et al.Increased use of second-generation macrolide antibacterials for children in nine health plans in the United States. Pediatrics 2004;114:12061211.Google Scholar
4.McCaig, LF, Besser, RE, Hughes, IM. Antimicrobial drug prescriptions in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis 2003;9:432437.CrossRefGoogle ScholarPubMed
5.Mainous, AG III, Hueston, WJ, Davis, MP, Pearson, WS. Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. Am J Public Health 2003;93:19101914.Google Scholar
6.Pakyz, AL, MacDougall, C, Oinonen, M, Polk, RE. Trends in antibacterial use in US academic health centers. Arch Intern Med 2008;168:22542260.CrossRefGoogle ScholarPubMed
7.World Health Organization (WHO). Collaborating Centre for Drug Statistics methodology: ATC index with DDDs. Oslo, Norway: WHO, 2004. Available at: http://www.whocc.no/atcddd/. Accessed January 6, 2009.Google Scholar
8.Grohskopf, LA, Huskins, WC, Sinkowitz-Cochran, RL, Levine, GL, Goldmann, DA, Jarvis, WR; the Pediatric Prevention Network. Use of antimicrobial agents in United States neonatal intensive care Patients. Pediatr Infect Dis J 2005;24:766773.CrossRefGoogle Scholar
9.Scheetz, MH, Knechtel, SA, Malczynski, M, Postelnick, MJ, Qi, C. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob Agents Chemother 2008;52:22562259.Google Scholar
10.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed January 24, 2009.Google Scholar